PCOS is Now PMOS: What the Name Change Means for You

If you're an individual living with PCOS, you may have recently seen the news. As of May 12th 2026, polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS). This is a significant moment for women's health, and one that as a women's health dietitian, gives me hope for more comprehensive treatment options for women managing this condition.

Here is what the name change means, why it happened, and what stays the same.

The Background

14 Years of Research Behind One Name Change

The name change was led by Professor Helena Teede from Monash University and published in The Lancet on May 12th 2026. It was the result of 14 years of global collaboration involving over 22,000 survey responses from clinicians, researchers, and people with lived experience across six continents.¹

PMOS (previously PCOS) affects 1 in 8 women worldwide, over 170 million people. Yet for decades, its name reduced a complex hormonal and metabolic condition to a misunderstanding about ovarian cysts.

The term PCOS implied that cysts on the ovaries were the defining feature of the condition. In reality, what were described as "cysts" are not true cysts at all. They are follicles with arrested development, a consequence of the broader hormonal disruption driving the condition. In the most recent diagnostic guidelines, examining the ovaries is not even necessarily required for diagnosis.

This contributed to:¹

• Missed or delayed diagnoses
• Insulin resistance and inflammation often being overlooked in treatment
• Skin, gut health, hair, weight, and mental health concerns going unaddressed

The New Name

What Does PMOS Actually Mean?

Every word in the new name was chosen deliberately to better reflect the true nature of the condition.

Polyendocrine

Recognises that the condition involves multiple interacting hormonal disturbances, including insulin, androgens, and neuroendocrine hormones. It is not an isolated ovarian disorder.

Metabolic

Acknowledges the metabolic features of the condition including insulin resistance, weight, and increased risk of type 2 diabetes and cardiovascular disease.

Ovarian Syndrome

Retains the connection to ovarian dysfunction, including ovulatory disturbances and fertility impacts, which remain defining features of the condition.

What Stays the Same

The Diagnostic Criteria Remains Unchanged

The name has changed, but the way PMOS is diagnosed has not. Women can be diagnosed with the condition if they have two out of three of the following criteria:¹

Rotterdam Diagnostic Criteria (unchanged)

• Irregular periods or absent ovulation
• Higher levels of androgens (male sex hormones), which may lead to increased facial or body hair, acne, weight changes, or hair thinning
• An ultrasound showing 20 or more fluid-filled follicles on the ovaries

Diagnosis should always be made by a doctor or specialist following appropriate investigation and assessment.

What This Means for Treatment

A More Complete Approach to Care

A key goal of the name change is to improve recognition and treatment of the condition across health disciplines. As Professor Piltonen, international co-lead of the name change process, stated: "With the name change we hope to capture better the true nature of the syndrome, involve more health professionals to identify the affected persons and take better care of them. Overall, we hope to improve the management and health of the women."

A more accurate name means more health professionals recognising PMOS for what it truly is: a complex, whole body hormonal and metabolic condition. This creates an opportunity for treatment that goes beyond a single intervention and draws on a broader team of health professionals.

Evidence-based support to consider alongside medical management

• Nutrition support targeted at insulin resistance, inflammation, supporting hormone and metabolic health
• Movement including resistance training, chosen in ways that are sustainable and enjoyable
• Mental health support to address the psychological impact of living with a complex, long-term condition
• Personalised supplementation guided by bloodwork and clinical assessment

A dietitian with experience in women's hormonal health can provide evidence-based, personalised nutrition support that helps manage both symptoms and the underlying metabolic and hormonal drivers of PMOS.

A Dietitian's Perspective

Why This Name Change Matters

As a women's health dietitian, this name change gives me hope. Better recognition of the hormonal and metabolic nature of PMOS means treatment can move beyond oversimplified advice. Women deserve care that addresses the full picture.

PMOS is a condition that affects so many dimensions of a woman's health. Digestion, skin, hair, weight, energy, mood, fertility, and long term metabolic health can all be impacted. When the name of a condition accurately reflects its complexity, it opens the door to better research funding, more appropriate treatment, and greater understanding from both clinicians and the community.

If you are living with PMOS and looking for personalised nutrition support, you don't have to navigate it alone. A women's health dietitian can provide simple, evidence-based support to help you understand your condition and manage it with confidence.

Please note: This blog post is for general educational purposes only and does not constitute personalised medical or dietetic advice. Always work with your doctor or a registered dietitian for personalised support with PMOS.

Wanting personalised nutrition support for PMOS?

Book a Free Discovery Call

Personalised dietitian support for PMOS and women's hormonal health. Calgary and online.

References

1. Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. Published online May 12, 2026. DOI: 10.1016/S0140-6736(26)00717-8. PMID: 42119588